Role of thrombolytic, antiplatelet, antithrombotic, and other drugs in the management of failed arterial grafts.
Welch
H J
HJ
Tufts University School of Medicine, Boston, MA.
O'Donnell
T F
TF
D000465:Algorithms; D000925:Anticoagulants / Q000627:therapeutic use*; D001158:Arteries / Q000601:surgery; D001807:Blood Vessel Prosthesis; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007430:Intraoperative Care; D007511:Ischemia / Q000601:surgery; D007866:Leg / Q000098:blood supply; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011138:Polytetrafluoroethylene; D011475:Prosthesis Failure; D012086:Reoperation; D017131:Thrombectomy; D015912:Thrombolytic Therapy / Q000379:methods
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011138:Polytetrafluoroethylene